Skip to main content

Synthetic Oligonucleotides in SPECT/CT In Vivo Imaging: Chemical Modifications, In111 Complex Formation, Incorporation into Drug Delivery Systems

  • Protocol
  • First Online:
  • 1351 Accesses

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1943))

Abstract

Here in we describe a solid phase synthesis of oligonucleotides bearing unnatural moiety appropriate for complex formation with In111 as well as their deprotection, isolation, and purification. We also present methods for oligonucleotides/In111 complex formulation with single and double stranded oligonucleotides of RNA nature and give an example of preparation method for one supramolecular drug delivery system (DDS) consisting of radiolabeled siRNA and positively charged peptide.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Ma DDF, Rede T, Naqvi NA, Cook PD (2000) Synthetic oligonucleotides as therapeutics: the coming of age. Biotechnology 5:155–196

    CAS  Google Scholar 

  2. Geary RS, Norris D, Yu R, Bennett CF (2015) Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv Drug Deliv Rev 87:46–51

    Article  CAS  Google Scholar 

  3. Park J, Park J, Pei Y, Xu J, Yeo Y (2016) Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Adv Drug Deliv Rev 104:93–109

    Article  CAS  Google Scholar 

  4. Ming X, Laing B (2015) Bioconjugates for targeted delivery of therapeutic oligonucleotides. Adv Drug Deliv Rev 87:81–89

    Article  CAS  Google Scholar 

  5. Otto P (1989) Investigation of the stability of oligonucleotides and polynucleotides. J Mol Struct THEOCHEM 188(3–4):277–288

    Article  Google Scholar 

  6. de Vries EFJ, Vroegh J, Dijkstra G, Moshage H, Vaalburg W (2004) Synthesis and evaluation of a fluorine-18 labeled antisense oligonucleotide as a potential PET tracer for iNOS mRNA expression. Nucl Med Biol 31:605–612

    Article  Google Scholar 

  7. Biosset high-performance DNA and RNA synthesisers (2011) http://biosset.com/. Accessed 1 Dec 2011

  8. GlenResearch catalog (2018) http://www.glenresearch.com/Catalog/index1.php

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Antopolsky, M. (2019). Synthetic Oligonucleotides in SPECT/CT In Vivo Imaging: Chemical Modifications, In111 Complex Formation, Incorporation into Drug Delivery Systems. In: Ogris, M., Sami, H. (eds) Nanotechnology for Nucleic Acid Delivery. Methods in Molecular Biology, vol 1943. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9092-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9092-4_5

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-9091-7

  • Online ISBN: 978-1-4939-9092-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics